|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 326.10 CHF | -1.18% |
|
+2.29% | -0.64% |
| 06-15 | Global drugmakers invest billions to boost US presence | RE |
| 06-15 | FDA Approves Roche Companion Diagnostic Test |  |
| Market Cap | 258B 326B 281B 243B 456B 30,785B 460B 3,053B 1,190B 15,076B 1,222B 1,196B 52,245B | P/E Ratio 2026 * |
17.4x | P/E Ratio 2027 * | 16.2x |
|---|---|---|---|---|---|
| Enterprise Value | 269B 339B 292B 252B 474B 32,014B 479B 3,175B 1,237B 15,677B 1,271B 1,244B 54,330B | EV / Sales 2026 * |
4.29x | EV / Sales 2027 * | 4.02x |
| Free-Float |
88.78% | Yield 2026 * |
3.09% | Yield 2027 * | 3.17% |
Last Transcript: Roche Holding AG
| 1 day | -1.18% | ||
| 1 week | +2.29% | ||
| Current month | -0.97% | ||
| 1 month | +1.02% | ||
| 3 months | +1.18% | ||
| 6 months | +1.78% | ||
| Current year | -0.64% |
| 1 week | 321.4 |  | 331.2 |
| 1 month | 306.4 | | 337.4 |
| Current year | 291 | | 374.9 |
| 1 year | 243.9 | | 374.9 |
| 3 years | 212.9 | | 374.9 |
| 5 years | 212.9 | | 404.2 |
| 10 years | 206.35 | | 404.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 2023-03-14 | |
Alan Hippe
DFI | Director of Finance/CFO | 59 | 2011-06-05 |
| Chief Operating Officer | - | 2025-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
André Hoffmann
BRD | Director/Board Member | 68 | 1995-12-31 |
Severin Schwan
CHM | Chairman | 59 | 2023-03-14 |
| Director/Board Member | 73 | 2015-03-02 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03-26 | Sell | 3,851 | 0.0036% | |||
| 02-25 | Buy | 7,984 | 0.0011% | |||
| 02-01 | Sell | 111 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.18% | +2.29% | +24.04% | +16.53% | 328B | |
| -0.61% | -1.94% | +39.00% | +150.72% | 1,007B | |
| -0.20% | -0.77% | +51.51% | +43.20% | 567B | |
| +0.40% | -1.31% | +16.56% | +60.47% | 392B | |
| -0.43% | +1.12% | +24.21% | +31.89% | 277B | |
| +0.64% | -2.55% | +22.80% | +12.69% | 275B | |
| -1.86% | +4.01% | -43.73% | -49.21% | 196B | |
| -0.77% | +0.95% | +17.69% | +51.46% | 189B | |
| +2.36% | +1.38% | +14.80% | +61.34% | 154B | |
| +0.15% | +1.32% | +6.72% | -35.00% | 148B | |
| Average | -0.16% | +0.68% | +17.36% | +34.41% | 353.42B | |
| Weighted average by Cap. | -0.29% | -0.17% | +26.56% | +62.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 62.58B 78.86B 67.96B 58.76B 110B 7,456B 111B 739B 288B 3,651B 296B 290B 12,653B | 65.13B 82.07B 70.73B 61.15B 115B 7,760B 116B 770B 300B 3,800B 308B 301B 13,169B |
| Net income | 15.16B 19.1B 16.46B 14.23B 26.72B 1,806B 27B 179B 69.77B 884B 71.68B 70.15B 3,064B | 16.22B 20.44B 17.62B 15.23B 28.59B 1,932B 28.9B 192B 74.67B 946B 76.71B 75.08B 3,280B |
| Net Debt | 10.31B 13B 11.2B 9.68B 18.18B 1,229B 18.37B 122B 47.48B 602B 48.77B 47.74B 2,085B | 3.44B 4.33B 3.73B 3.23B 6.06B 410B 6.12B 40.62B 15.83B 201B 16.26B 15.91B 695B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-16 | 324.00 CHF | -0.64% | 881,895 |
| 26-06-15 | 326.10 CHF | -1.18% | 1,460,078 |
| 26-06-12 | 330.00 CHF | +1.44% | 1,125,149 |
| 26-06-11 | 325.30 CHF | +0.43% | 1,371,862 |
| 26-06-10 | 323.90 CHF | +1.60% | 1,329,930 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROP Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition